Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mary E. Costantino"'
Autor:
Shannon L. Reynolds, Sameer R. Ghate, Richard Sheer, Pranav K. Gandhi, Chad Moretz, Cheng Wang, Stephen Sander, Mary E. Costantino, Srinivas Annavarapu, George Andrews
Publikováno v:
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-9 (2017)
Abstract Background Novel oral anticoagulants (NOAC) such as dabigatran, when compared to warfarin, have been shown to potentially reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) together with lower healthcare resou
Externí odkaz:
https://doaj.org/article/155ea9dc7e534a27aa8cf5f05b5317cc
Autor:
Mikele Bunce, Dana Drzayich Antol, Aparna Raj Parikh, Adrianne Waldman Casebeer, Todd Michael, Mary E. Costantino, Alisha Stein, Stephen Stemkowski, Sari Hopson, Andrew Renda, Raya Khoury
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-1 (2021)
Journal of Patient-Reported Outcomes
Journal of Patient-Reported Outcomes
Studies have demonstrated that comorbidities compound the adverse influence of cancer on health-related quality of life (HRQoL). Comorbidities adversely impact adherence to cancer treatment. Additionally, adherence to medications for comorbidities is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97dd8319b344b95de4204e55658c8b29
https://doi.org/10.1186/s41687-021-00300-6
https://doi.org/10.1186/s41687-021-00300-6
Autor:
Mette Hammer, Mary E. Costantino, Andrew Renda, Jonathan Bouchard, Pravin Kamble, Brandon T. Suehs, Joanna Huang
Publikováno v:
Current Medical Research and Opinion. 33:2173-2180
To examine the association of obesity with healthcare resource utilization and costs in a Medicare population.This study was a retrospective cohort study using Humana Medicare Advantage (MA) claims data. Body mass index (BMI) was assessed using ICD-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e13b0167297ba619b9d2c0e16962c539
https://doi.org/10.1080/03007995.2017.1361915
https://doi.org/10.1080/03007995.2017.1361915
Autor:
Mikele Bunce, Aparna Raj Parikh, Andrew Renda, Adrianne Waldman Casebeer, Raya Khoury, Sari Hopson, Dana Drzayich Antol, Todd Michael, Mary E. Costantino, Alisha Stein, Stephen Stemkowski
Publikováno v:
Journal of Patient-Reported Outcomes
Journal of Patient-Reported Outcomes, Vol 2, Iss 1, Pp 1-12 (2018)
Journal of Patient-Reported Outcomes, Vol 2, Iss 1, Pp 1-12 (2018)
BackgroundStudies have demonstrated that comorbidities compound the adverse influence of cancer on health-related quality of life (HRQoL). Comorbidities adversely impact adherence to cancer treatment. Additionally, adherence to medications for comorb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5da58b903ff3b52996dfa9fe1a880924
https://doi.org/10.1186/s41687-018-0057-2
https://doi.org/10.1186/s41687-018-0057-2
Autor:
Sameer R. Ghate, George Andrews, Cheng Wang, Richard Sheer, Srinivas Annavarapu, Pranav K. Gandhi, Shannon L. Reynolds, C. Moretz, Mary E. Costantino, Stephen Sander
Publikováno v:
Health and Quality of Life Outcomes
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-9 (2017)
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-9 (2017)
Background Novel oral anticoagulants (NOAC) such as dabigatran, when compared to warfarin, have been shown to potentially reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) together with lower healthcare resource utili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bf717b001e5cd6b363b8f24df1b5bcb
https://doi.org/10.1186/s12955-017-0705-x
https://doi.org/10.1186/s12955-017-0705-x
Autor:
Kim R. Saverno, Ahmad AL-Sabbagh, Mary E. Costantino, John Orazem, Larry Z. Liu, Sari Hopson, Margaret K Pasquale
Publikováno v:
Journal of managed carespecialty pharmacy. 22(2)
Biologic disease-modifying antirheumatic drug (DMARD) therapies are a mainstay of treatment for rheumatoid arthritis (RA), yet high member out-of-pocket (OOP) costs for such therapies may limit patient access to these therapies.To understand whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9184d1c7f1607da2633cca5db844bf6b
https://pubmed.ncbi.nlm.nih.gov/27015251
https://pubmed.ncbi.nlm.nih.gov/27015251
Autor:
Yongqing Liu, Mary E. Costantino, Douglas C. Dean, Yujiro Higashi, Diego E. Montoya-Durango, Douglas S. Darling
Publikováno v:
Biochemical Journal. 408:79-85
ZFHX1A is expressed in proliferating cells in the developing embryo, and in the present study we provide evidence that its expression is confined to proliferating cells through dependence on the Rb (retinoblastoma protein) family/E2F cell cycle pathw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ece61183d59164c72d146b10a0183228
https://doi.org/10.1042/bj20070344
https://doi.org/10.1042/bj20070344
Publikováno v:
Biochemical and Biophysical Research Communications. 296:368-373
Zinc finger homeodomain enhancer-binding protein (Zfhep/Zfhx1a) is a transcription factor essential for immune system development, skeletal patterning, and life. Regulation of the interleukin-2 gene in T cells has been suggested to depend on post-tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a54914a9e02f81dff0d1db63fe922fc
https://doi.org/10.1016/s0006-291x(02)00880-x
https://doi.org/10.1016/s0006-291x(02)00880-x
Publikováno v:
Population health management. 17(5)
The objective was to estimate health care costs and utilization for Medicare beneficiaries with type 1 (T1DM) or type 2 (T2DM) diabetes and their respective matched control cohorts. A retrospective claims cohort analysis was used to assess direct hea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef03c8d4a6eb04397c5b696e22ccc88f
https://pubmed.ncbi.nlm.nih.gov/24865764
https://pubmed.ncbi.nlm.nih.gov/24865764
Publikováno v:
Population health management. 16(5)
Hospital readmissions in the Medicare population may be related to a number of factors, including reoccurrence of illness, failure to understand or follow physician direction, or lack of follow-up care, among others. These readmissions significantly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::331177628e501acdcd29eb4675525192
https://pubmed.ncbi.nlm.nih.gov/23537154
https://pubmed.ncbi.nlm.nih.gov/23537154